CCND1 and cancer: It also inhibited cyclin D1 and disrupted the G1 cell cycle phase in HCT-116 cancer cells [3,6] At high doses (>3 μM), curcumin functions as an alkylating agent in CRC, preventing cancer cell multiplication while sparing healthy cells.